Discontinued — last reported Q3 '25
ResMed Intangibles (Net) decreased by 1.2% to $425.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $430.11M to $425.19M. Over 4 years (FY 2021 to FY 2025), Intangibles (Net) shows an upward trend with a 4.3% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $392.58M | $375.40M | $372.01M | $355.98M | $345.94M | $338.15M | $586.86M | $569.68M | $552.34M | $563.28M | $528.18M | $501.02M | $485.90M | $478.61M | $438.00M | $430.11M | $464.86M | $447.07M | $430.24M | $425.19M |
| QoQ Change | — | -4.4% | -0.9% | -4.3% | -2.8% | -2.3% | +73.5% | -2.9% | -3.0% | +2.0% | -6.2% | -5.1% | -3.0% | -1.5% | -8.5% | -1.8% | +8.1% | -3.8% | -3.8% | -1.2% |
| YoY Change | — | — | — | — | -11.9% | -9.9% | +57.8% | +60.0% | +59.7% | +66.6% | -10.0% | -12.1% | -12.0% | -15.0% | -17.1% | -14.2% | -4.3% | -6.6% | -1.8% | -1.1% |